Inspire Medical Systems Q3 EPS $(0.29), Sales $153.30M Inline
Portfolio Pulse from Benzinga Newsdesk
Inspire Medical Systems (NYSE:INSP) reported Q3 losses of $(0.29) per share, beating the analyst consensus estimate of $(0.58) by 50 percent. This is a 51.67 percent increase over losses from the same period last year. The company also reported quarterly sales of $153.30 million, meeting the analyst consensus estimate, and marking a 40.40 percent increase over sales from the same period last year.
November 07, 2023 | 9:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Inspire Medical Systems reported better than expected Q3 earnings and met sales estimates. This could potentially have a positive impact on the company's stock.
Inspire Medical Systems reported a smaller loss than expected and met sales estimates, which is generally seen as positive news by investors. This could lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100